0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The Combination of 17α-Hydroxyprogesterone and 11-Epicortisol Prevents the Delayed Feedback Effect of Natural and Synthetic Glucocorticoids

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Subcutaneous injection of 400 µg/100 g body weight of corticosterone (B) 2 h previously in male rats prevented the stress response, as assessed by the ability of adrenal glands removed from these animals to produce endogenous B. Two injections of a combination of 17α-hydroxyprogesterone and 11-epicortisol, the first given 30 min before and the second with the B, were able to block this inhibitory effect on the stress response. Neither of the steroids alone was effective in this regard. The combination was also effective against the early delayed feedback effects of 400 µg/100 g body weight cortisol, prednisolone or beclomethasone dipropionate in the same system. The minimum effective dose for reversal of feedback by B or beclomethasone dipropionate (2 mg/100 g body weight of each antagonist) was lower than that required for the same effect against prednisolone or cortisol (5 mg/100 g body weight). Previous injection of B also abolished the ability of anterior pituitary gland fragments to respond to corticotropin-releasing factors (CRFs) added in vitro, an effect which was not abolished by the injection of the combination of putative antagonistic steroids. From experiments designed to measure the ability of 17α-hydroxyprogesterone and 11-epicortisol to compete with <sup>3</sup>H-corticosterone in binding to macromolecular components in hypothalamic, hippocampal and pituitary cytosolic preparations, it was deduced that the competition seen in the hypothalamic and hippocampal, rather than the pituitary, preparations was in better accord with the effect seen on the stress response. These results, taken together with our studies of the effects of the two steroids on CRF release from the hypothalamus in vitro, suggest that the site of action of 17α-OH-progesterone and 11-epicortisol is at the hypothalamus (and/or higher centres) and not at the pituitary gland.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1986
          1986
          01 April 2008
          : 43
          : 4
          : 491-497
          Affiliations
          Divisions of aGynaecology and bBiochemistry, United Medical and Dental Schools, London; cRoyal Holloway and Bedford New College, Egham, Surrey, UK
          Article
          124572 Neuroendocrinology 1986;43:491–497
          10.1159/000124572
          3748307
          © 1986 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Categories
          Original Paper

          Comments

          Comment on this article